CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic solutions. This gene-editing tool has been adapted for molecular ...
Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...
(a) Utilizing HCR and CRISPR-Cas12a double amplification technique, a highly sensitive apta-HCR-CRISPR method was devised for the detection of TEV protein. (b) A novel CRISPR-Cas12a/Cas13a approach, ...
The clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated proteins (Cas) system is a bacterial defense mechanism that uses RNA-guided enzymes to cut specific sequences ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
In this issue of BioTechniques, we present the development of a novel antibody for the detection of fMet-bearing proteins across different species, a method for characterizing the microbiome ...
SAN DIEGO & BRISBANE, Calif.--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, ...
VedaBio has entered a non-exclusive licensing agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for diagnostic purposes. This collaboration grants VedaBio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback